GEGurcan Erbay

Gurcan Erbay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gurcan Erbay has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic Value of MRI‐Derived Apparent Diffusion Coefficient in Intermediate‐Risk Prostate Cancer Treated With Definitive Radiotherapy

    by Cem Onal, Gurcan Erbay, Aysenur Elmali, Birhan Demirhan, Ozan Cem Guler

    Background: Intermediate‐risk prostate cancer (IR‐PCa) is a heterogeneous disease with variable clinical outcomes despite established risk classification. We evaluated whether pretreatment tumor apparent diffusion coefficient (ADC) derived from multiparametric MRI was associated with long‐term outcomes and provided additional prognostic information beyond established clinical risk classification in patients treated with definitive radiotherapy. Methods and Materials: We retrospectively analyzed 238 patients with IR‐PCa treated with definitive radiotherapy. Tumor ADC values were obtained from pre‐treatment diffusion‐weighted MRI. Patients were stratified according to ADC levels and clinical risk subgroups, including favorable and unfavorable intermediate‐risk disease. Survival analyses and Cox regression models were used to assess associations between ADC and clinical outcomes, including biochemical failure and distant metastasis. Results: At a median follow‐up of 10.3 years, 22 patients developed biochemical failure, and 12 developed distant metastases. Lower ADC values (≤ 0.668 × 10 −3  mm 2 /s) were associated with inferior outcomes, with a significant impact on freedom from distant metastasis (FFDM) (HR 3.94, 95% CI 1.14–13.62; p = 0.03). When ADC was combined with clinical risk classification, outcomes differed across the four resulting subgroups for both FFDM ( p = 0.02) and FFBF ( p = 0.02). However, the FIR–low ADC subgroup included only seven patients, and these subgroup findings should be considered exploratory. Conclusions: Lower tumor ADC was associated with an increased risk of distant metastasis and provided exploratory prognostic information beyond established clinical risk classification. Given the limited number of events and the data‐derived cutoff, these findings require external validation before ADC can be used to guide treatment selection.

  • Open Access

    Diagnostic Performance of Expert Physicians Versus General-Purpose Artificial Intelligence Using Standardized Static Coronary CT Images: A Dual-Reference Validation Study

    by Sefa Okar, Ziya Gökalp Bilgel, İsa Öztürk Balcı, Gurcan Erbay, Mustafa Yılmaz

    BackgroundCoronary CT angiography (CCTA) is a first-line diagnostic modality for coronary artery disease, yet its interpretation requires expert experience. Although general-purpose multimodal artificial intelligence (AI) models have shown promise in text-based medical tasks, their diagnostic performance in CCTA remains unclear.MethodsThis single-center retrospective diagnostic accuracy study included 63 patients who underwent both CCTA and invasive coronary angiography. Expert physician consensus and four general-purpose AI models evaluated identical standardized static curved multiplanar reformatted images. Obstructive disease was defined as ≥50% luminal stenosis. Plaque characterization was assessed against final clinical CCTA reports and expert consensus, while stenosis severity was validated using quantitative coronary angiography (QCA).ResultsExpert consensus demonstrated strong agreement with QCA across all coronary arteries (κ = 0.774–0.933, p <0.001). In contrast, none of the AI models achieved statistically significant agreement in the left anterior descending or left main coronary arteries. Continuous stenosis correlation and plaque characterization performance were limited and inconsistent across models.ConclusionExpert interpretation remains the reference standard for CCTA assessment. Current general-purpose AI models are not suitable for independent clinical interpretation of coronary CT angiography.

  • Open Access

    Comparison of Characteristics and Survival of New-Onset Hepatocellular Carcinomas With or Without Cirrhosis in a Tertiary Center

    by Filiz Araz, Barış Soydaş, Birol Özer, Elif Karadeli, Gürcan Erbay

    Background/Aims: Although hepatocellular carcinoma (HCC) usually develops in cirrhotic livers, HCCs could also arise in non-cirrhotic livers. We aimed to compare the characteristics and survival of cirrhotic- and non-cirrhotic HCCs. Materials and Methods: Data of HCC patients between 2011 and 2021 in a single tertiary center was evaluated retrospectively. Demographic, clinical, laboratory, tumoral and pathological features, and survival outcomes of cirrhotic and non-cirrhotic HCCs were compared. Results: The study included 188 HCC patients. Median age was 64 (26-92) years and similar for study groups (P = .208). Both groups had similar male/female ratio. Forty-two patients (22.3%) had HCC in non-cirrhotic liver. Non-cirrhotic HCCs had similar tumor differentiation type, radiological characteristics, Milan, University of California San Francisco, and the Barcelona Clinic Liver Cancer stages, but more unifocal lesion (78.6% vs. 59.6%) and larger tumor size (89.5 (16-240) mm vs. 59.0 (12-290) mm) at presentation compared to non-cirrhotic HCCs. Despite larger tumor size, non-cirrhotic HCC patients had better overall, disease-free and progression-free survival rates than cirrhotic HCCs. Overall survivals for 1 and 3 years were 71.4% and 49.7% for non-cirrhotic and 54% and 28.3% for cirrhotic HCCs, respectively (P = .035). According to Cox analyses, Eastern Cooperative Oncology Group score (P < .001, hazards ratio (HR): 4.05) and curative treatments (P < .001, HR: 0.21) were predictive for overall survival in cirrhotic HCCs. Curative treatment (P = .027, HR: 0.31) was found to be a significant predictor for overall survival in non-cirrhotic HCCs. Vascular invasion was the only independent predictor for disease-free survival (HR: 2.62, 95% CI 1.01-6.93, P = .049) for non-cirrhotic HCCs. Conclusion: Despite larger tumor size and similar tumor stages, compared to cirrhotic HCCs, non-cirrhotic HCCs were associated with better survival outcomes. Cite this article as: Araz F, Soydaş B, Özer B, Karadeli E, Erbay G. Comparison of characteristics and survival of new-onset hepatocellular carcinomas with or without cirrhosis in a tertiary center. Turk J Gastroenterol. 2024;35(7):539-550.


  • High-Flow Priapism and the Importance of the Piesis Maneuver: A Case Report

    by Mehmet Reşit Gören, Mehmet Vehbi Kayra, Cevahir Özer, Gürcan Erbay, Çağatay Andıç

  • Open Access

    Anormal uterin kanama ile seyreden tümör trombüsünün nadir bir nedeni olarak uterin leiomyomatozis

    by Gürcan Erbay, Umur Anıl PEHLİVAN

    Uterine leiomyomatosis as a rare cause of tumor thrombus presenting with abnormal uterine bleeding

  • Open Access

    Leiomyomatosis peritonealis disseminata mimicking peritoneal carcinomatosis

    by Gürcan Erbay, Çiğdem Yalçin

    Disseminated peritoneal leiomyomatosis is a benign and very rare disease usually affecting premenopausal women. We present a 39 year old lady with intramural leiomyoma and disseminated peritoneal leiomyomatosis. The definitive treatment of disseminated peritoneal leiomyomatosis is surgical, depending on the degree of the disease. Before deciding on aggressive treatment, it should be kept in mind that peritoneal fibroids can mimic malignant peritoneal tumors.

  • Open Access

    Use of Histogram Analysis in Diffusion-Weighted Magnetic Resonance Imaging for Differentiation of Renal Tumor Subgroups

    by Gurcan Erbay, Mehmet Resit Goren, Elif Karadeli, Burcak Pekoz, Zafer Koc, Sami Arica

    Background: The histopathological differentiation of renal neoplasms can be challenging via imaging. Objectives: To evaluate differences in histogram parameters on apparent diffusion coefficient (ADC) maps and to investigate the efficacy of histogram analysis in differentiation of oncocytomas from malignant renal neoplasm (MRN) subgroups. Patients and Methods: In this cross-sectional, retrospective study, the texture parameters of diffusion-weighted magnetic resonance images (DW-MRI) were evaluated in 65 patients with renal tumors (nine cases of oncocytoma and 59 cases of MRN) for a histological analysis. Results: A total of 68 lesions from 50 male and 15 female patients, with a median age of 55.4 years, were examined in this study. There were significant differences in the mean, median, and peak ADC values, as well as ADC percentiles, between the oncocytoma and MRN subgroups. Regarding the histopathological features of the lesions, 9 (11.5%) cases of oncocytomas, 23 (29.5%) cases of clear cell renal carcinoma (ccRCC), 14 (17.9%) cases of papillary renal cell carcinoma (pRCC), 12 (15.4%) cases of chromophobe renal cell carcinoma (chRCC), and 10 (12.8%) other tumors (including four cases of transitional cell carcinoma, four cases of non-Hodgkin’s lymphoma, and two cases of primitive neuroectodermal tumor) were identified. Significant differences were found in the mean and median ADC values between the oncocytoma, pRCC, chRCC, and other MRN subgroups. Moreover, significant differences were found in the mean and median ADC values between the ccRCC, pRCC, and chRCC subgroups. There were also significant differences in the percentiles of mean and median ADCs between oncocytomas and pRCC, chRCC, and other MRN subgroups. However, there were no significant differences in the mean and median ADCs (including the percentile histogram analysis) or the peak ADC between the oncocytoma and ccRCC groups. The mean, median, and percentile of ADC for renal masses were superior to kurtosis, skewness, and entropy. Conclusion: Although differentiation between ccRCC and oncocytoma was not possible by only measuring the mean, median, and peak ADC values, the histogram analysis of ADCs may improve differentiation between the MRN subgroups. Clearly, ADC cannot be used to differentiate between oncocytomas and MRNs.